Africa’s Malaria Battle: Fake Drug Pipeline Undercuts Progress (WSJ)

A study published last year by the Lancet medical journal and conducted by a unit of the National Institutes of Health found that 35% of 2,300 malaria drug samples tested in sub-Saharan Africa were of “poor quality”—either fake, expired or badly made.

Read the Story